Hydralazine Hydrochloride USP

Hydralazine hydrochloride is a chemically defined heterocyclic compound with nitrogen hetero-atoms, specifically an aromatic phthalazine derivative used as a direct-acting peripheral vasodilator. It falls under HTS 2933.99.51.00 as a cardiovascular drug in pure form for pharmaceutical manufacturing or compounding. This powder form meets Chapter 29 note (a) for separate chemically defined organic compounds.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
πŸ‡¨πŸ‡³ChinaFreeβ€”Free
πŸ‡²πŸ‡½MexicoFreeβ€”Free
πŸ‡¨πŸ‡¦CanadaFreeβ€”Free
πŸ‡©πŸ‡ͺGermanyFreeβ€”Free
πŸ‡―πŸ‡΅JapanFreeβ€”Free

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

2933.99.97.01Higher: 6.5% vs Free

If not specifically listed as a cardiovascular drug

Other aromatic heterocyclic drugs fall here if not enumerated in 2933.99.51.00; hydralazine could be classified as 'other' absent specific drug designation.

2941.90.10Same rate: Free

If imported as stabilized salt form with excipients exceeding Chapter 29 tolerances

Antibiotics and derivatives with added stabilizers may shift to 2941 if additions render it outside pure compound scope per Chapter notes.

3004.90Higher: 10% vs Free

If pre-formulated into dosage units like tablets or capsules

Finished medicaments shift from Chapter 29 bulk APIs to Chapter 30 as presented for retail therapeutic use.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

β€’ Provide Certificate of Analysis (CoA) confirming USP grade purity >98% and identity via HPLC to avoid reclassification as non-pharmaceutical chemical

β€’ Include FDA Drug Master File (DMF) reference and end-use statement specifying pharmaceutical manufacturing to qualify for drug tariff treatment

β€’ Ensure proper hazardous material declaration (UN 2811) as toxic substance; common pitfall is inadequate stability data for shelf-life claims